Spotlight Case July 2008 Dependence vs. Pain. 2 Source and Credits This presentation is based on the July 2008 AHRQ WebM&M Spotlight Case –See the full.

Slides:



Advertisements
Similar presentations
Spotlight Case March 2005 The Hidden Mystery. 2 Source and Credits This presentation is based on the March 2005 AHRQ WebM&M Spotlight Case in Hospital.
Advertisements

Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
© 2007 Thomson - Wadsworth Chapter 13 Nutrition Care and Assessment.
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
OPIOIDS I. Where do they come from? / synthesized in 1803
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Spotlight Medication Reconciliation With a Twist (or Dare We Say, a Patch?)
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Pain and Chemical Dependency Not an “Either – Or” proposition Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Centre, Toronto ON.
Substance Abuse. Heroin What Is It…  Highly addictive drug that is processed from morphine  Morphine: comes from the opium poppy, a flower that grows.
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Spotlight Case Treatment Challenges After Discharge.
Two Wrongs Don't Make a Right (Kidney)
Substance Abuse Issues in Health Professionals Shannon V Chavez, MD Chair, UCSD Physician Well-Being Committee Director, UCSD Health Professional Program.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Medical Model of Addiction
Presented By Dr/ Said Said Elshama
Spotlight Case The Safety and Quality of Long Term Care.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Chapter 4 Screening and Assessment of Alcohol/Drug Problems.
Major Depressive Disorder Presenting Complaints
Understanding Drug Use 1. Drug / Psychoactive Substance Any substance that when taken by a person modifies : Perception Mood Cognition Behaviour Motor.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
HIV and Injection Drug Use
The Pains of Chronic Opioid Usage
Spotlight Case Delay in Treatment: Failure to Contact Patient Leads to Significant Complications.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Ken Saffier, MD, Natasha Pinto, MD And Patients CCRMC/HC Noon Conference February 18, 2010.
Spotlight Case Emergency Error. 2 Source and Credits This presentation is based on the June 2013 AHRQ WebM&M Spotlight Case –See the full article at
Spotlight Case February 2004 Delay in Antibiotics— A Fatal Mistake.
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
OPIATES Kendell Hodgden. DEFINES/DESCRIBES OPIATES referred to as narcotics a group of drugs which are used medically to relieve pain have a high potential.
OPIOIDS I. Where do they come from? –poppy plant: from middle east and Asia –dried sap from plant is opium; cultivated annually BUT plant produces drug.
OPIOIDS I. Where do they come from? –poppy plant: from middle east and Asia –dried sap from plant is opium; cultivated annually BUT plant produces drug.
NYU Medicine Grand Rounds Clinical Vignette Himali Weerahandi, PGY3 March 6, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Opioid Dependence Anne Kalvik Pearl Isaac. Learning Objectives 1.To develop an understanding of opioid dependence issues including tolerance, abuse, toxicity,
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
NYU Medical Grand Rounds Clinical Vignette Christopher Schultz, MD, PGY-2 February 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
PERCODAN ABUSE *And Other Prescription Abuse* Kirsten Neilson Life, Society & Drugs Section 004.
ADOLESCENTS IN CRISIS: WHEN TO ADMIT FOR SELF-HARM OR AGGRESSIVE BEHAVIOR Kristin Calvert.
1 HIV and Injection Drug Use HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Clinical aspects Module 4. Steps Assessment Criteria for treatment Treatment plan Induction Monitoring Evaluation.
Addiction and dependence Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
PRESCRIPTION PAINKILLER ABUSE AND ADDICTION KAREN REYES BIOLOGY UNIVERSITY OF HOUSTON-DOWNTOWN.
Spotlight Case Postdischarge Follow-Up Phone Call.
Spotlight Case Watch the Warfarin!. 2 Source and Credits This presentation is based on the July 2011 AHRQ WebM&M Spotlight Case –See the full article.
Spotlight Case Peripheral IV in Too Long. 2 Source and Credits This presentation is based on the September 2012 AHRQ WebM&M Spotlight Case –See the full.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Substance Abuse Chapter 11. Substance Abuse  Self-administration of a drug in a manner that does not conform to the norms within the patient’s own culture.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Gregory S. Brigham, Ph.D., CEO
Incidental Medical Services (IMS) Department of
Current Concepts in Pain Management
Clinical Opiate Withdrawal – Symptom Management Protocol
Medication-Assisted Therapy at Coleman Profession Services
Painkiller, How it Effects People
Drug Use as a Social Problem
Presented by J. Arzaga, MSN, RN
UConn Health John Dempsey Hospital
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Risk Management During Opioid Analgesic Prescribing for Chronic Pain
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
Treating Opioid Withdrawal with Buprenorphine/Naloxone
Medically assisted treatment
Tapering and Discontinuing Chronic Opioid Therapy
Opiate misuse among our seniors
Acute Pain Management & Addiction
Presentation transcript:

Spotlight Case July 2008 Dependence vs. Pain

2 Source and Credits This presentation is based on the July 2008 AHRQ WebM&M Spotlight Case –See the full article at –CME credit is available Commentary by: Adam J. Gordon, MD, MPH University of Pittsburgh School of Medicine –Editor, AHRQ WebM&M: Robert Wachter, MD –Spotlight Editor: Bradley Sharpe, MD –Managing Editor: Erin Hartman, MS

3 Objectives At the conclusion of this educational activity, participants should be able to: Define opioid dependence and opioid withdrawal syndrome Describe the treatment of opioid withdrawal syndrome including the use of Clinical Opioid Withdrawal Scale (COWS) and pharmacologic treatments Appreciate the stigma associated with opioid dependence and the potential impact on the quality of care provided

4 Case: Dependence vs. Pain A 56-year-old man with a long history of heroin use presented to the hospital with abdominal pain, nausea, and vomiting. He said he had been using less heroin than usual because of the gastrointestinal complaints and felt his symptoms were probably from heroin withdrawal. On initial evaluation, he was dehydrated but his vital signs were unremarkable, and his abdominal exam was benign. Complete blood count, liver function tests, amylase, and lipase were all normal. An upright KUB radiograph showed no clear cause for his abdominal pain.

5 Case: Dependence vs. Pain (2) Admitted for treatment of dehydration and opiate withdrawal, the patient was given intravenous fluids, methadone, and low doses of morphine for the abdominal pain. Later in the evening, he complained of increasing diffuse abdominal pain. He also complained of excessive yawning and increased lacrimation. On physical examination, he was tachycardic, tachypneic, and generally restless, but had a non-tender abdominal examination. He was given increased methadone to treat presumed worsening opiate withdrawal.

6 Opioid Dependence Defined as a maladaptive pattern of use of illicit or prescription opioids leading to significant impairment or distress as manifested by the presence of 3 or more of the diagnostic criteria in past 12 months See Notes for reference.

7 Diagnostic Criteria for Opioid Dependence 3 or more of following criteria in past 12 months  Physical dependence  Tolerance  Taking opioids in larger amounts or for longer periods than intended  Desiring to cut down or control use  Dedicating a large amount of time to procure opioids or recover from their effects  Giving up important activities because of use  Using opioids despite knowledge of harm See Notes for reference.

8 Scope of the Problem More than 3 million Americans have used heroin in their lifetime In 2000, up to 1 million individuals addicted to heroin in US 2 million people used prescription pain relievers for non-medical reasons in % of 12 th graders report using hydrocodone within the past year See Notes for references.

9 Medical and Societal Costs Illicit opioid use associated with significant harm to individuals Strains health care system Major medical and psychiatric illnesses often co-exist with opiate addiction, such as depression, hepatitis, HIV Violence and crime can also be associated

10 The Presented Case The patient in the case likely has the disorder of opioid dependence The patient presented with symptoms consistent with classic opioid withdrawal

11 Diagnostic Criteria for Opioid Withdrawal Three or more symptoms that include  Dysphoric (negative) mood  Goosebumps or sweating  Nausea or vomiting  Diarrhea  Muscle aches  Yawning  Runny nose or watery eyes  Fever  Dilated pupils  Insomnia

12 Opioid Withdrawal Symptoms may be severe, cause significant distress, and often impair functioning Many opioid dependent individuals continue to use opiates only to avoid withdrawal Opioid withdrawal is generally managed in the outpatient setting in methadone treatment facilities (licensed Opioid Agonist Therapy [OAT] programs)

13 Treating Opioid Withdrawal Methadone and buprenorphine are available to treat opiate withdrawal and provide longer term maintenance for opiate dependence For patients hospitalized with acute medical illness, primary concern should be stabilizing the patient –Short “detoxification” course of opioids Emerging research has outlined protocols See Notes for references.

14 Issues in Present Case In this case, the provider’s original working diagnosis was opioid withdrawal syndrome Even if this diagnosis is suspected, complete history and physical examination, as well as appropriate lab studies, should be performed

15 Issues in Present Case (cont.) Patient’s yawning, lacrimation, tachycardia, tachypnea, restlessness, and non-tender abdominal exam are consistent with opioid withdrawal However, overt abdominal pain is rare Prescribing intravenous morphine would not be treatment of choice for opioid withdrawal Important to look for other causes of his abdominal pain and worsening condition

16 Other Factors in Diagnosis and Treatment Patients with opioid dependence may present with comorbid conditions such as HIV, Hepatitis C, or skin infections These disorders may require specific treatment, or may influence the treatment of other illnesses

17 Case (cont.): Dependence vs. Pain Despite the methadone increase, the patient’s abdominal pain persisted and worsened. Overnight, a covering physician was contacted about the abdominal pain. The nurse told the physician that the patient had asked for something stronger for the pain.

18 Case (cont.): Dependence vs. Pain Because the daytime physician had earlier described the patient as a “strung-out shooter,” the covering physician believed the patient was either drug seeking through his complaints of pain or not receiving enough methadone. Instead of re-evaluating or re-examining the patient, the covering physician ordered another increase of methadone. The patient continued to have diffuse abdominal pain and tachycardia overnight.

19 Case (cont.): Dependence vs. Pain In the morning, the patient’s abdominal pain became severe, his tachycardia worsened, and his blood pressure decreased—indicating a possible infection (septic shock). The patient was given aggressive intravenous fluids. An abdominal computed tomography (CT) scan revealed a perforated colon, likely from diverticulitis. The patient then underwent successful colonic resection and was discharged from the hospital 2 weeks later.

20 What Went Wrong Patient’s worsening in the face of opioid agonist therapy should have triggered the covering physician to consider another diagnosis Unfortunately, providers may have negative perceptions about patients with alcohol or drug disorders Such stigma may contribute to misdiagnosis or delays in diagnosis, as well as worse health outcomes See Notes for references.

21 Relapse Rates in Chronic Illness Comparing alcohol/drug disorders with other chronic diseases (e.g., diabetes, hypertension), relapse rates to unhealthy behavior are similar Adherence to MD recommendations in hypertension generally poor –< 40% of patients adhere to antihypertensive regimens –< 30% of patients adhere to diet or behavioral changes 50%-70% of patients with hypertension experience relapse of disease annually Similarly, alcohol and other drug use disorders have relapse rates between 40%-60% See Notes for references.

22 Disorder as Chronic Illness Alcohol and other drug disorders may be considered chronic medical illnesses requiring ongoing care and not just “quick fixes” Effective, evidence-based treatments are available, and providers should appropriately screen, identify, and treat these patients

23 Improving Quality of Care for These Patients Improved education in substance abuse disorders for trainees and practicing clinicians may also improve the quality of care Hospitals and health care systems should consider structured mechanisms to ensure appropriate treatment of opioid dependence and opioid withdrawal

24 Take-Home Points Opioid dependence is a chronic, treatable medical condition The clinical opioid withdrawal scale (COWS) can be a useful objective measure of opioid withdrawal Methadone and buprenorphine treatments are available for treatment of both opioid dependence and opioid withdrawal syndrome Providers should be suspicious of atypical presentations of opioid withdrawal and evaluate patients accordingly